Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.

The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.

According to our latest research, the global Epigenetic market size will reach USD 11500 million in 2028, growing at a CAGR of 7.4% over the analysis period 2022-2028.

Global Epigenetic Scope and Market Size

This report focuses on the global Epigenetic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epigenetic development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.


Segment by Type


Reagents

Kits

Instruments

Enzymes

Services


Segment by Application


Academic Research Institutes

Biotechnology Companies

Biopharmaceutical Companies

Diagnostic Companies

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa


By Company


Illumina

Qiagen

Abcam

Merck & Co

Sigma-Aldrich

New England Biolabs

Thermo Fisher Scientific

Diagenode

Active Motif

Roche Diagnostics

Eisai

Novartis